Ensuring every newborn has access to life-saving screening and treatment is both a moral and economic imperative.' ...

Myriad Genetics (NASDAQ:MYGN) traded higher on Wednesday after Piper Sandler upgraded the cancer test developer to Overweight ...

A large genome-wide association study meta-analysis analyzed data on 42 female reproductive health diagnoses from the ...

With thousands of rare diseases affecting millions of families worldwide, one Tampa Bay lawmaker is taking action to position Florida as a national leader in genetic medicine.

What Happened? Shares of genetic testing company Myriad Genetics (NASDAQ:MYGN) jumped 10.6% in the morning session after Piper Sandler analysts upgraded the stock's rating from Neutral to Buy. The ...

Genetics plays a crucial role in the manifestation and progression of over 6,800 rare diseases, including but not limited to, genetic disorders, rare ...

It seems like no matter what I do, I can't lose weight. Most of my family members struggle with their weight too. Do our ...

A new study from Oxford Population Health has revealed that lifestyle choices and environmental factors have a much bigger ...

Two studies led by researchers at the Broad Institute of MIT and Harvard and Mass General Brigham have greatly expanded the ...

Fulgent Genetics exceeded expectations in the fourth quarter of 2024, showcasing robust revenue growth and a GAAP loss.

Assessing productivity in a beef herd can be done using a range of different metrics. In many cases producers focus on some ...